You have no items in your cart.
CRISPR/Cas9 Gene Editing May Correct Genetic Defect in DEB, Study Suggests
Epidermolysis Bullosa News
A CRISPR/Cas9-based gene editing strategy was able to restore production of type VII collagen protein (C7) in skin cells from a patient with severe dystrophic epidermolysis bullosa (DEB), a study ... Read more